Related by context. All words. (Click for frequent words.) 77 xvii 75 xix 73 xvi 72 viii 72 xxi 71 xiii 71 xxii 70 xii 70 xv 68 xiv 67 xxvi 67 vii 66 xxiii 65 ix 64 xxvii 64 xxiv 64 iv 63 xxv 62 iii 61 Immtech clinical trials 60 xi 60 vi 60 xxviii 57 ii 55 Immtech scientists 54 Pure Biofuels ability 54 xxxiii 52 multiple lease terminations 52 risksassociated 52 xxxii 52 substantial indebtedness 51 ourability 51 representations warranties covenants 50 changesin 50 legal proceedings xxi 50 general economicconditions 50 risks associatedwith 50 withrespect 49 date xvii Conversion 49 ability tosuccessfully 49 vii viii 49 regarding Heska 49 CAUTION ANY ATTEMPT 49 materially adversely affect 49 retrocessional coverage 48 DSL.net s 48 requirements xxii 48 § #.#-# [004] 48 HANA MAX 48 suchforward looking 48 REIT xi 48 xxix 48 filingswith 48 USC § #a [002] 48 lender consents 48 postretirement benefit obligations 48 risks anduncertainties 48 #.#-# b [002] 48 associated therewith 47 technological obsolescence 47 #.#-# b [001] 47 otherfactors 47 OSI Pharmaceuticals filings 47 collect reinsurance recoverables 47 HealthGate ability 47 otherrisks 47 affecting mortality morbidity 47 contingently liable 47 notlimited 47 incurrence 47 Direct Indirect x 47 tenant bankruptcies 47 Crisa acquisition 47 including withoutlimitation 47 statementsregarding 47 timing rescheduling 46 communicate differentiations effectively 46 thereunder 46 relatedto 46 § #-#-# [005] 46 EPIXTAR 'S 46 xiv licensing 46 adverse determinations 46 deCODE filings 46 Unitholder liability 46 Johnell O 46 theability 46 SumTotal Systems filings 46 Equinix filings 46 successfully integrate 46 without limitation Terremark 46 ceded reinsurance 46 unanticipated difficulties 45 contingent guaranties 45 #.# subd [003] 45 nonoccurrence 45 PLAVIX R patent 45 xxxi 45 competitively procured pursuant 45 i #.# subds 45 Thalomid R 45 risks associated 45 affirmative covenants 45 inventory obsolescence 45 USC § #f 45 § #-#-# b [003] 45 Kanis JA 45 results ofoperations 45 h r 45 [013] 45 § #.#-# [007] 45 PharMerica LTC Transaction 45 orotherwise 45 Gastroesophageal Reflux 45 impactof 45 EMPOWER pivotal trial 45 Market Disruption 45 without limitation 45 BY AN ENTRANT 45 thereby negatively impacting 45 maydiffer materially 45 refund guarantors 45 Somaxon ability 45 OneBeacon filings 45 SANCTURA SANCTURA XR VANTAS 45 orother 45 Analysis C.1 Strengths 45 governmental approvals 45 incur unanticipated 44 SURETY LICENSES c 44 d Represents 44 Item IA 44 indebtedness covenant 44 Projects Initiation 44 market fluctuations investee 44 VIOXX Lawsuits 44 assorted pigments resins 44 work stoppages quarantines 44 CFR § #.# [004] 44 PDI periodic filings 44 d Reflects 44 USC § #u 44 vi vii 44 others Mannatech inability 44 § #-#-# b [001] 44 areforward looking 44 involverisks 44 affecting Amarin 44 P. #a 44 securityholder approvals 44 risks associated therewith 44 xxxv 44 Yima project 44 iii iv 44 Legal #.# 44 Shire Attention Deficit 44 Omtool periodic reports 44 CFR #.# [006] 44 e# periodic 44 Shire plc Attention Deficit 44 CFR § #.# [005] 44 postretirement benefit plans 44 vii IBC 44 Heska reliance 44 f h 44 EHSK 44 expenses associated therewith 44 Form #KSB filed 44 #.# subd [004] 44 rapid technological 44 pandemics impacting 44 Lenfest ii 44 liabilities slippage 44 xv licensing 44 renegotiation nullification 43 borrower depositor 43 obsolete inventory 43 CFR § #.# [006] 43 xvi beer 43 i g 43 AspenTech periodic reports 43 Offerors Commercial applies 43 deploy MDCE services 43 materially adversely affected 43 Excess Cash Flow 43 risksand uncertainties 43 rights xix xx 43 postretirement benefit 43 differ materially 43 heading RISK FACTORS 43 xxvi introduction 43 arenot limited 43 amendments thereto 43 limitedto 43 affecting IsoTis 43 i# implanters 43 Bioenvision filings 43 CFR #.#b 43 Second Supplemental Indenture 43 infringement invalidity 43 Securities andExchange Commission 43 CFR #.# [002] 43 AudioCodes filings 43 affecting Pennichuck Corporation 43 outbreaks epidemics 43 related thereto 43 dd DISCOUNTS R 43 pricing pressures 43 prepayment speeds loan originations 43 periodic redeterminations 43 uncertaintiesthat 43 Company noncontributory defined 43 Navios Partners filings 43 materially differ 43 DFAR #.#-# 43 ADSI reliance 43 ultimate recoverability 43 constitutes discloseable transaction 43 Colo. Sess 43 HF Lenfest member 43 reasonably determinable 43 party VLSI fabrication 43 DTR #.#.# b 43 y u 43 punitive incidental 42 DISMISSED WITH PREJUDICE 42 Secure Computing periodic 42 #g# 2 42 Terremark filings 42 JLG acquisition 42 economicconditions 42 unanticipated 42 adversely affecting Cubist 42 differ materially fromthose 42 Candente relies upon 42 ExchangeCommission 42 Tronox Annual Report 42 Vion Annual Report 42 SeraCare competitors 42 current physiologic opioid 42 ofsuch 42 c Relates 42 Income Tax Regs 42 See USSG § #B#.# 42 differ materiallyfrom 42 postretirement benefits 42 theavailability 42 executed supplemental indenture 42 heading ITEM 1A 42 reinsurance recoverable 42 economically recoverable coal 42 Iusacell Celular 42 theSecurities 42 delinquencies defaults 42 Defendants misrepresented 42 NASD Marketplace Rule 42 #.#A [005] 42 acquisitions dispositions 42 aresubject 42 forwarda ^ looking 42 factors thatcould 42 SUPPRELIN LA DELATESTRYL 42 marketconditions 42 indentures governing 42 Cautionary Disclosures 42 associatedwith 42 u h 42 Tekmira disclaims any 42 #.#-# #.#-# #.#-# #.#-# 42 #.#-# [016] 42 persistency mortality 42 filedwith 42 obtaining regulatory approvals 42 unitholder liability 42 Nortek Holdings 42 Repl. 42 #.#-# Offeror Representations 42 RR Donnelley periodic filings 42 looking statements.Such 42 TranSwitch filings 42 b Reflects 42 Optimer filings 42 brine inflows 42 prescription brands RESTYLANE 42 #,#,# Commitments 42 adversely affect 42 Gottschalks Annual Report 42 contingent liabilities 42 causeactual results 42 BioSante licensees 42 technological innovations adversely affecting 42 Form# K 42 market PolyHeme commercially 42 intercompany arrangements 42 c html plugins 42 Waratah Coal filings 42 couldcause 42 REMOVAL Removal shall 42 promulgated thereunder 42 garantie 42 r l 42 Convertible Notes tendered 42 DARA intellectual property 42 FierceGovernmentIT tracks 42 CFR § #.# [008] 42 Financing Condition 41 uncertainties 41 I. Item 1A 41 #.# subd [006] 41 incorporate proprietary Microvolt 41 AXXX 41 TranSwitch indebtedness 41 visit http:/www.nationwide.com 41 qW 41 OCGA § #-#-#.# 41 RISKS AND UNCERTAINTIES 41 anduncertainties 41 retail industries repositionings 41 reinsurance recoverables owed 41 USC § #k 41 PolyMedix filings 41 SciClone filings 41 positive inotropic agents 41 Kung sila pa rin 41 f o 41 Atheros Quarterly Report 41 u t 41 Probable 2P 41 n h r 41 Accruals 41 CFR #.# [008] 41 Invitel Holdings operates 41 majeure 41 SANCTURA SANCTURA XR NEBIDO 41 vii Dynamic 41 Risks uncertainties 41 Black Canyon mica 41 R DYNACIN R 41 h u 41 des paiements 41 manganese ii 41 riesgo 41 inversión 41 #.# 5T 41 TCA § #-#-# [003] 41 d h 41 Radware filings 41 w illus 41 de la société 41 adversely affect Waste Connections 41 relating 41 differmaterially 41 Attached hereto 41 Oxandrin R 41 affect Petroflow 41 Contingent liabilities 41 retrocessional reinsurance 41 USEB Chapter 41 Entrust periodic 41 LOPROX R 41 Subordinate MBS 41 § #a [002] 41 Indentures governing 41 intercompany indebtedness 41 Tucows filings 41 g h 41 GulfMark filings 41 Regulation XXX 41 Erythropoietic therapies may 41 Genitope Corporation filings 41 intellectual property litigations 41 - -Billeaudeau 41 AUCTIONEER CONSIGNOR OR 41 xiv unanticipated 41 unfavorable geologic 41 Toreador intends 41 #.#-# Equal Opportunity 41 h g 41 restrictive covenants contained 41 currency fluctuations imprecision 41 molecular immunohematology products 41 h y 41 work stoppages slowdowns 41 #.#-# [020] 41 ofany 41 mergers consolidations 41 Cephalon GlaxoSmithKline Organon 41 Lordsburg Mining District 41 § #.# [004] 41 consolidations restructurings bankruptcies 41 b 41 collectibility 41 Excluding acquisitions divestitures 41 Form 8K #K 41 stata 41 § #-#-#.# 40 Subordinated Debentures 40 Oxandrin 40 Univest Corporation files 40 subordinated indebtedness 40 Congoleum undertakes 40 c Reflects 40 vii Cubist ability 40 manufacture PolyHeme 40 Textainer expectation 40 suchstatements 40 reject unexpired 40 Navios Holdings filings 40 refinance indebtedness 40 Julius Peppers DE 40 xii trademark 40 reinsurance ceded 40 § #-#.# [003] 40 Contingent Liabilities 40 FSAH 40 Esterhazy Saskatchewan potash 40 Interest Drawdown Date 40 #.#-# [001] 40 CHDT SEC Filings 40 See USSG § #D#.# 40 t h r 40 TeamStaff filings 40 love veronica Mars 40 ecommerce marketplaces 40 involve risksand uncertainties 40 HealthTronics periodic filings 40 xi unanticipated 40 consiste 40 DIP Loan 40 include SUPERPRETZEL PRETZEL 40 nancial 40 cancellations rescheduling 40 OMNI dependence 40 SEC Rule #g# 40 t r 40 #,#,# #,#,# Commitments [002] 40 elective deferrals 40 subparagraph B 40 las condiciones 40 n h 40 y h 40 mergers dispositions 40 INVESTMENT PLAN 40 applies prospectively 40 r h 40 deben 40 cadence regulatory approvals 40 Bo Scaife TE 40 Certifications Commercial 40 FGIC insured 40 b Represents 40 customary representations warranties 40 o l 40 thepotential 40 SANCTURA R 40 prices drydocking 40 candidate Ramoplanin 40 dispositions joint ventures 40 Varvarinskoye Project 40 unanticipated geological 40 Favrille filings 40 A. Neal Auction 40 carryforwards 40 execute supplemental indenture 40 IMPAX filings 40 gathering compressing treating 40 Theseforward looking 40 OPAXIO pixantrone 40 ARLP Partnership 40 diminishing quantities 40 couldcause actual results 40 ourproducts 40 g o 40 PGP Acquisition 40 recoverables 40 #.#-# Instructions 40 TGS reliance 40 Exchange Act 40 - Adjusted [017] 40 consummating acquisitions 40 Mago ® 40 DTR#.# 40 successfully commercialize 40 Qualstar filings 40 Miraculins cautions 40 permitting timelines 40 Vion Form 40 See USSG § #A#.# 40 VYVANSE TM lisdexamfetamine 40 en vertu de la 40 surety bonding increased 40 theCompany 40 Absentee Telephone 40 tarmac strandings Hanni 40 xv adverse 40 p r 40 adversely affect Univest Corporation 40 Sonus Annual Report 40 Refinancing Transactions 40 depreciation depletion amortization 40 passenger Silver Whisper 40 product introductions 40 Markland Technologies filings 40 Publication Classified Ad 40 l h 40 BOPET film industry 40 reinsurance cessions 40 noncurrent liabilities 40 capture exosomes 40 #,#,# #,#,# -DH Ellis Burks 40 thispress release 40 FAR #.#-# Offeror Representations 40 examinations vaccinations spaying 40 IRC § 40 fluctuations 40 SEK -#.# -#.# [003] 40 VanceInfo filings 40 OraTest R 40 acquisitions divestitures joint ventures 40 Exelbine 40 Multiemployer Pension Plan 40 postretirement 40 VIOXX Product 40 DELETE OR EDIT COMMENTS 40 § #A.# 39 Amends Existing 39 de certains 39 involve risks anduncertainties 39 Bioenvision dependence 39 viii inability 39 -Amos Harel Haaretz Correspondent 39 NJSA #:#-# [004] 39 adversely affect FNB 39 iaculis 39 attribution authenticity provenance 39 toreflect 39 paul dev da 39 CompAir acquisition 39 postemployment benefits 39 sequencing gene expression 39 b Vernon Supp 39 Protonix ® 39 est que 39 Ferlay J et al 39 Derivative instruments 39 credit carryforwards 39 visit http:/www.tronox.com 39 de ses 39 lo que se 39 indentures pursuant 39 PD2i Analyzer ™ 39 mortality persistency 39 - -Denis Restoule 39 integrate CyVera technology 39 BiDil XR drug 39 e h r 39 nonhematologic adverse reactions 39 pharmacotherapeutics 39 CFR #.# [005] 39 mandatorily redeemable preferred 39 shipper ie 39 personnel xvii inability 39 EDGAR Online via COMTEX 39 Date xiv 39 may diverge numerically 39 mensaje 39 OneBeacon Annual Report 39 inaccurately estimating 39 Nephros filings 39 Nortel unfunded 39 LogicVision disclaims 39 non si ha 39 Fourth Supplemental Indenture 39 Insolvency Proceedings 39 infringed misappropriated invalid 39 ii Immtech ability 39 risks unanticipated reclamation 39 STRANDED BRAIN GENIUS 39 #,#,# #,#,# Commitments [003] 39 maycause actual results 39 natural disasters epidemics 39 documentation evidencing 39 muscles abdominal distension 39 adversely affect NextEra Energy 39 Shire plc filings 39 inherent uncertainty 39 non capitalizable 39 ` @ gn 39 Securitiesand Exchange Commission 39 soient 39 wv ` 39 className nodes nodes.length = 39 Healthvision acquisition 39 B. Neal Auction 39 uncertainties materialize Shire 39 y r 39 proprietary Capillary Aerosolization Technology 39 shipyards charterers lenders 39 jurisdictional prerequisite 39 PD2i Analyzer TM 39 - -seemingly unquenchable 39 theseforward looking 39 early extinguishments 39 arising therefrom 39 Acorda Therapeutics intellectual property 39 en tant 39 VimpelCom disclaims 39 reinsurance recoverables 39 sublease recoveries 39 Inventory write downs 39 sites xix limitations 39 LOUIS Oshiomogho Atogwe 39 reestimates 39 Vernon Supp 39 Fed.R.Civ.P. 39 forward lookingstatements 39 workersa compensation 39 SiriCOMM periodic reports 39 arebased 39 inflammatory autoimmune diseases 39 PAIVIS actual 39 Reinsurance recoverables 39 #.#-# Affirmative Action 39 Aircastle Limited filings 39 Detrex stock 39 looking statements.These 39 Partial Tender Offer 39 Charlie Manuel flips 39 eTelcharge.com Inc. 39 STRIANT R 39 transportation storage terminalling 39 FalconStor OEM 39 unforeseen occurrences 39 #.#-# Contract Terms [002] 39 obligations hereunder 39 illiquid restricted 39 neutropenia thrombocytopenia 39 celui qui 39 minerals inc 39 ii iii 39 la situación 39 maycause 39 uncertainties materialize Shire plc 39 supplemental indenture containing 39 Cerro Negro concession 39 doubtful accounts receivable 39 AUCTIONEER reserve 39 Direct xi Indirect 39 BioGlue ® 39 CORLUX CORT # 39 Thelin tm 39 l o 39 expropriation nationalization 39 Duska intends 39 successfully commercialize Silenor 39 contemplated thereunder 39 CompX 39 neurological disorders orthopedic 39 ftit 39 PLIVA acquisition 39 liabilities# [001] 39 aux côtés 39 § #c 39 Minimum Tender Condition 39 Unearned Premiums 39 en actions ordinaires 39 traer 39 AMPS Risk 39 li il 39 gli di 39 vigorously enforces 39 Colihues tailings impoundment 39 TOLL BROTHERS INC. AND 39 fringilla 39 NET INCREASE IN 39 safeharbor 39 Reorganized Debtors 39 treatment emergent hyperglycemia 39 Note Indenture 39 XVII inability 39 - -Commey 39 AMENDMENT OF 39 EXPENSES Employee Compensation 39 VELCADE therapy 39 breast tenderness bloating 39 PS# Pharmacopeia ability 39 #.#-# Combating Trafficking 39 un placement privé 39 LOVE YOU ALL 39 Verena filings 39 § #.# [002] 39 InfoSearch filings 39 Innodata Isogen acquires 39 negations thereof generally 39 PD2i Cardiac Analyzer 39 cranes Fuchs 39 Master Commutation Release 39 Chase Kishner 39 suivants 39 Kyowa Kirin 39 str = i 39 further reassort 39 incorporating FalconStor 39 consiste en 39 installata sul proprio pc 39 Mircette R 39 AMETEK filings 39 consummation 39 TRUSTCASH 39 Notes Indenture 39 Rexahn actual 39 CholeraGarde R Peru 39 Extends Maturity Date 39 website www.gladiatorstocks.com 39 merchant chargebacks 39 Pharmos filings 39 Risk Factors 39 Risk Factors section 39 l w 39 tkun 39 Liability Lawsuits 38 deriving synergies 38 Ala. R. Civ 38 HIPAA Gramm Leach Bliley 38 attaching thereto 38 Immersion disclaims 38 placement prive 38 Consists primarily 38 vQsQn 38 o h 38 principally attributable 38 Puricase PEG uricase 38 cedents 38 tendering holders 38 EIHI cautions 38 xviii currency 38 #,# - Commitments [002] 38 Daytrana TM 38 includingstatements regarding 38 Lordsburg mill comprising 38 ALL PROPERTIES ARE SOLD 38 Company periodic filings 38 Agreement constitutes discloseable 38 j 38 Rexahn licensees 38 GrowthWorks refers 38 Direct Indirect 38 SCHIP Extension 38 neque 38 Termination Benefits 38 # wQ 38 OTC ZEGERID 38 mmoore@equicomgroup.com 38 anyforward looking 38 réaliser 38 Radware Form 38 Compans 38 recompetes 38 viii insufficient 38 OCGA § #-#-# [005] 38 commercialize ZYFLO CR 38 Document de Référence 38 Hyperactivity Disorder ADHD 38 historicalfacts 38 Repligen filings 38 IDO Annual Report 38 CFR § #.# [007] 38 WAIVER OF WARRANTY 38 website www.PennyStockAlley.com 38 men bisexuals transgender 38 indications contraindications 38 CalGen 38 Merger Transactions 38 Certifications Commercial Items 38 AvenEx 38 obligations thereunder 38 Dimension BST 38 intents beliefs 38 Zanaflex Capsules 38 .W. McNichols 38 competing steel minimills 38 subsections b 38 indexation clauses 38 LAE reserves 38 @ y qW 38 ASUR filings 38 USC § #a [001] 38 actualresults 38 MGCD# MGCD# [001] 38 Atheros Annual Report 38 therein 38 forward lookingstatement 38 AMFM Notes 38 Somewhat mitigating 38 inability 38 dans le cadre 38 withinthe meaning 38 ma il 38 Questcor intellectual property 38 STARLIMS filings 38 mettre un 38 â € œwill â 38 factorsthat 38 aux actionnaires 38 Assurance Pensions 38 § #.#.# [002] 38 Abraxis assumes 38 kollu 38 underlying sulfide mineralization 38 excluding drydocking 38 collaborations Pharmacopeia 38 purchaserâ € ™ 38 REIT Exemption 38 Accrued severance 38 TRIOLEX HE# APOPTONE HE# 38 worsening peripheral neuropathy 38 Baqoubah north 38 Web site http:/www.EmergingStockReport.com 38 Partially offset 38 quant à 38 ghandu 38 unsecured indebtedness 38 amort 38 Non Correlation 38 microsurgical disciplines 38 applicable Offering Memorandum 38 USED IN FINANCING ACTIVITIES 38 Existing Debentures 38 b Relates 38 materially impair 38 andeconomic 38 DIP Facility 38 Affymax Quarterly Report 38 - Commitments [011] 38 Carolinas Unfavorable primarily 38 c Excludes 38 Reports Inducement Grants 38 self insured retentions 38 § #-#.# [001] 38 Seabridge cautions 38 EVIZON TM squalamine lactate 38 Megi packed 38 KRYSTEXXA TM 38 especially Copaxone ® 38 Brascan SoundVest Funds 38 l u 38 Senior Secured Debentures 38 drawing painting gouache 38 looking statementsare 38 bone marrow fibrosis 38 dispositions financings 38 MGCD# MGCD# [002] 38 DR #.#.# 38 adversely affecting 38 personnel xviii inability 38 Noneconomic damages 38 XP# XP# 38 unforeseen calamities 38 governmental payors 38 Taleo Annual Report 38 acquisitions divestitures mergers 38 Macrovision assumes 38 MHG Annual Report 38 inaccuracy therein 38 Risks Related 38 Ascendiant 38 TriPath Oncology 38 uncollectability 38 reasonably estimable 38 w l 38 Golf Course Nudity Warnin 38 e mail lifestyle@readingeagle.com 38 dimesylate Attention Deficit 38 rainwater dripped onto 38 kulhadd 38 Inverse Floaters 38 la forma 38 redeterminations 38 ayuda 38 Infor expressly disclaims 38 within themeaning 38 USC § #b [001] 38 x fluctuating beryllium 38 acquisitions divestitures 38 Lasertel subsidiary 38 CDO financings 38 Jekk 38 Micromem filings 38 ¤ ¤ ¤ ¤ 38 PXRE undertakes 38 website www.FreePennyAlerts.com 38 footnotes thereto 38 OR FOR DISCRETIONARY 38 #.#-# [006] 38 disinterested Shareholder approval 38 Jupiterimages respective 38 Control Triggering Event 38 Partnered Brands segment 38 uncollectible accounts receivable 38 Illiquidity Risk 38 INACCURACIES 38 Hiru Corp. 38 Knoxville MSA 38 ha dado 38 calcium hypochlorite markets 38 Reg. S 38 Modifiable risk 38 infrequently occurring 38 mhw ` 38 franking credits attached 38 AnnualReport 38 - + [008] 38 NNL failure 38 APDN SEC 38 assume NO RESPONSIBILITY 38 retrocessions 38 hereunder shall 38 § #-#-# [002] 38 Dynegy cautions 38 bioMETRX filings 38 humana 38 datos 38 h 38 gastrointestinal GVHD include 38 party payors 38 Proposed Financing 38 mixtures thereof 38 MIGENIX assumes 38 b Excludes 38 noticeably thinner stark 38 NRSRO ratings 38 Auxilium anticipates 38 Debenture Indenture 38 products visit www.adm.com 38 NONCURRENT LIABILITIES 38 Oligator R oligonucleotides iv 38 Zemiva TM Trofex TM 38 § #-# [004] 38 FAR #.#-# Instructions 38 constitute discloseable transaction 38 accounting pronouncements 38 include ClindaReach TM 38 Solzira TM 38 indemnification clauses 38 FSP #-# 38 Indevus undertakes 38 iehor 38 wiehed 38 andrelated 38 Unlimited Closeouts purchases overstocks 38 Debtors estates 38 ARPU CPGA 38 theforward looking 38 XL# anticancer compounds 38 Juhl Wind subsequent 38 TP# CETi 1 38 successfully commercialize Iluvien 38 Profile Research AMXL.MX Quote 38 prepetition liabilities 38 PROCHIEVE ® 38 Convertible debenture 38 Shigamabs 38 yn gweithio 38 c Represents 38 Offeror Representations 38 Acapodene R 38 mandatorily redeemable 38 impacting WesBanco 38 SumTotal Enterprise 38 alguna 38 liquidating Filene Basement 38 ceding commissions 38 DECREASE IN CASH AND 38 #.# subdivision [004] 38 USC § #a [003] 38 anticipated drydocking 38 CAUTIONARY STATEMENT Statements 38 Enpath ability 38 #.#-# [005] 37 periodic reports 37 Subparagraph 37 commercialized Analyte Specific Reagents 37 meaning ascribed thereto 37 c SIGA 37 professionals technological obsolescence 37 subds 37 onForm 37 indebtedness 37 menores 37 mortality morbidity 37 respect thereto 37 theSecurities Act 37 hon yn 37 Preliminary Prospectus Supplement 37 Filtran Microcircuits Inc. 37 coûts 37 u ma 37 vendor unseasonable weather 37 site www.buyins.net